Megestrol Acetate Tablets

Listing ID #960530

Get Latest Price

Supply Type Manufacturer, Exporter, Supplier
Preferred Buyer Location All over the world

Megestrol Acetate Tablets are extensively used for treating breast and endometrial cancers. The name of our company surfaces prominently among the trusted Manufacturers, Exporters and Suppliers of Megestrol Acetate Tablets from Delhi, India. The Megestrol Acetate Tablets that we offer are formulated in accordance with the set industry standards. Indications : Breast cancer Endometrial cancer Dosage Adjustment : Renal Impairment : Not required, administer with caution. Hepatic Impairment : Required. Packing : 30 Strips of 10 Tablets

Send Enquiry

Company Details

United biotech pvt. Ltd. (ubpl), one of the fastest growing pharmaceutical company in india, was established in 1997. A multi-crore entity, with who-cgmp and iso 9001:2008 certified state-of-the-art manufacturing facility, has strategic tie-ups with several mncs, apart from having one of the most exciting product pipelines in the industry today.
Ubpl embodies a very human spirit by always remaining at the forefront to introduce lifesaving drugs for serving ailing mankind. Over the years, united biotech's name has come to stand for scientific innovation, vision and integrity and is rooted in its founding father's passion for progress. The innovativeness, competitiveness and a will to succeed against all odds are the qualities that are at the heart of ubpl culture. All this synergise with the dream of our founder, who has spent his lifetime in the pursuit of his mission of providing world class speciality healthcare products at affordable costs.
Our quality products today reaches to 55 countries making us a force to reckon with in exports too. Today we are registered in 49 countries and are well poised to make a mark in regulated markets as well.
Marching forward, our dynamic research and development abilities, best in class manufacturing capabilities and sharp marketing acumen, will take us far and ahead. We will continuously benchmark and evaluate ourself in our mission to become a globally acclaimed pharmaceutical company.